NASDAQ:VOR
Vor Biopharma Inc. Stock News
$1.74
+0.0600 (+3.57%)
At Close: May 15, 2024
Why You Shouldn't Bet Against Vor Biopharma (VOR) Stock
09:36am, Thursday, 04'th Apr 2024
Vor Biopharma (VOR) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
Vor Bio to Participate in Upcoming Investor Conferences
08:00am, Monday, 01'st Apr 2024
CAMBRIDGE, Mass., April 01, 2024 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that it will participate in the following upcoming inv
The Penny Stock A-List: 7 High-Profile Companies on the Verge of Greatness
02:28pm, Thursday, 28'th Mar 2024
In most cases, investors should stay away from penny stocks. They're wild, they're unpredictable and they tend to lose their stakeholders money more so than they return.
Vor Bio to Participate in Upcoming Investor Conferences
08:00am, Monday, 04'th Mar 2024
CAMBRIDGE, Mass., March 04, 2024 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that it will participate in the following upcoming inv
Vor Bio (VOR) Up on Positive Update From AML Cell Therapy Study
09:26am, Friday, 19'th Jan 2024
Vor Bio (VOR) stock gains after dosing the first patient in its phase I/II study of novel cell therapy, VCAR33 (Allogenic), to treat AML. The company extends its cash runway into the second half of 20
Vor Bio to Participate in Upcoming Investor Conferences
08:00am, Friday, 03'rd Nov 2023
CAMBRIDGE, Mass., Nov. 03, 2023 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that it will participate in the following upcoming inve
Vor Bio to Participate in Upcoming Investor Conferences
08:00am, Monday, 25'th Sep 2023
CAMBRIDGE, Mass., Sept. 25, 2023 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that it will participate in the following upcoming inv
Vor Bio to Participate in Upcoming Investor Conferences
08:00am, Wednesday, 30'th Aug 2023
CAMBRIDGE, Mass., Aug. 30, 2023 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that it will participate in the following upcoming inve
Top 5 Health Care Stocks That Could Lead To Your Biggest Gains In July - Cibus (NASDAQ:CBUS), Bellerophon Therapeutics (NASDAQ:BLPH)
08:51am, Wednesday, 05'th Jul 2023
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
Vor Bio to Participate in Upcoming Investor Conferences
08:00am, Tuesday, 18'th Apr 2023
CAMBRIDGE, Mass., April 18, 2023 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that it will participate in the following upcoming inv
How Much Upside is Left in Vor Biopharma Inc. (VOR)? Wall Street Analysts Think 172.06%
11:29am, Tuesday, 28'th Mar 2023
The mean of analysts' price targets for Vor Biopharma Inc. (VOR) points to a 172.1% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement amo
Vor Biopharma: Very Interesting Idea For Improving CAR-T Through Stem Cells
03:13pm, Monday, 27'th Mar 2023
Vor Biopharma Inc. is the brainchild of Dr. Siddhartha Mukherjee. Its core idea is to make CAR-Ts safer by using stem cells.
Vor Bio Announces Q4 And FY 2022 Results
02:08pm, Friday, 24'th Mar 2023
Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, reported its financial results for the three-month period and full year that ended December 31, 2022, and provided a busine
Vor Bio to Participate in Upcoming Investor Conferences
08:00am, Tuesday, 21'st Feb 2023
CAMBRIDGE, Mass., Feb. 21, 2023 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that it will participate in the following upcoming inve
Vor Bio to Present at B. Riley Securities' 3rd Annual Oncology Conference
08:00am, Thursday, 12'th Jan 2023
CAMBRIDGE, Mass., Jan. 12, 2023 (GLOBE NEWSWIRE) -- Vor Biopharma (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that it will participate virtually in B. Riley Se